|
|
|
|
|
|
|
Achieve Life Sciences- Inc. (ACHV)
|
|
3.18 0.38 (13.57%)
|
08-20 12:08
|
|
Open:
|
2.94
|
Pre. Close:
|
2.8
|
|
High:
|
3.18
|
Low:
|
2.91
|
|
Volume:
|
79,683
|
Market Cap:
|
14M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.893 - 2.917
|
2.917 - 2.933
|
|
Low:
|
2.663 - 2.688
|
2.688 - 2.705
|
|
Close:
|
2.766 - 2.806
|
2.806 - 2.833
|
|
|
|
Technical analysis (as of: 2018-08-20 11:44:48 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.
|
|
Target:
|
Six months: 3.72  One year: 4.09
|
|
Support:
|
Support1: 2.67 Support2: 2.22
|
|
Resistance:
|
Resistance1:
3.18 Resistance2: 3.50
|
|
Pivot:
|
3.13
|
|
Moving Averages:
|
MA(5): 2.92 MA(20): 3.18
MA(100): 7.82 MA(250): 13.65
|
|
MACD:
|
MACD(12,26):
-0.32 Signal(12,26,9): -0.37
|
|
%K %D:
|
%K(14,3): 27.57 %D(3): 23.85
|
|
RSI:
|
RSI(14): 38.41
|
|
52-Week:
|
High: 42
Low: 2.67 Change(%): -89.1
|
|
Average Vol(K):
|
3-Month: 100442
10-Days 8861
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ACHV has closed above bottom band by 38.7%. Bollinger Bands are 71.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACHV's normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-08-08T18:52:07-04:00
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript
2018-08-08T16:12:09-04:00
Achieve Life Sciences reports Q2 results
2018-08-08T16:05:00-04:00
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
